Iksuda Therapeutics Competitors and Similar CompaniesClear all

Iksuda Therapeutics's competitors and similar companies include Immutep, Bold Therapeutics, Artiva Biotherapeutics and Bexion Pharmaceuticals.
Iksuda Therapeutics
Iksuda Therapeutics
Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer.
Immutep
Immutep
Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.
Bold Therapeutics
Bold Therapeutics
Bold Therapeutics is a biotechnology company developing cancer therapy for the treatment of gastric, pancreatic, colorectal, and other cancers.
Artiva Biotherapeutics
Artiva Biotherapeutics
Artiva Biotherapeutics is a company that develops off-the-shelf cell therapies designed to treat hematologic malignancies or solid tumors.
Bexion Pharmaceuticals
Bexion Pharmaceuticals
Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments.
Founding Date
Founding Date
2007
Founding Date
2001
Founding Date
2018
Founding Date
2019
Founding Date
2006
Type
Type
Private
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Newcastle upon Tyne, GB HQ
Newton, US
Locations
Sydney, AU HQ
Sydney, AU
The Rocks, AU
Orsay, FR
Berlin, DE
Leipzig, DE
Locations
Vancouver, CA HQ
Locations
San Diego, US HQ
Locations
Covington, US HQ
Employees
Employees
43
Employees
2427% decrease
Employees
205% increase
Employees
81
Employees
274% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
282.4 m
Valuation ($)
N/A
Valuation ($)
263.8 m
Valuation ($)
N/A

Financial

Net income
Net income
N/A
Net income
($61.4m) (FY, 2025)
Net income
N/A
Net income
($83.9m) (FY, 2025)
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 47m (almost 5 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 16.6m (about 7 years ago)
Total funding raised
Total funding raised
$ 47m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 78m
Total funding raised
$ 16.6m
For sources of this data, please see the company profile

View Company Profiles

Immutep
HQ
Sydney, AU
Employees
24↓ 27% decrease

Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.

View company
Bold Therapeutics
HQ
Vancouver, CA
Employees
20↑ 5% increase

Bold Therapeutics is a biotechnology company developing cancer therapy for the treatment of gastric, pancreatic, colorectal, and other cancers.

View company
Artiva Biotherapeutics
HQ
San Diego, US
Employees
81

Artiva Biotherapeutics is a company that develops off-the-shelf cell therapies designed to treat hematologic malignancies or solid tumors.

View company
Bexion Pharmaceuticals
HQ
Covington, US
Employees
27↑ 4% increase

Bexion Pharmaceuticals is a company committed to the discovery, clinical development, and acquisition of oncology treatments.

View company